NanoViricides Inc Stock OTC Bulletin Board
Equities
US6300871042
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.96M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.51
x | P/E ratio 2025 * |
-0.99
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.68% |
Managers | Title | Age | Since |
---|---|---|---|
Anil Diwan
CEO | Chief Executive Officer | 66 | 05-03-31 |
Meeta Vyas
DFI | Director of Finance/CFO | 66 | 13-05-12 |
Jayant Tatake
CTO | Chief Tech/Sci/R&D Officer | - | 10-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Zucker
BRD | Director/Board Member | 62 | 20-11-12 |
Anil Diwan
CEO | Chief Executive Officer | 66 | 05-03-31 |
Director/Board Member | 73 | 20-02-06 |
1st Jan change | Capi. | |
---|---|---|
-2.56% | 103B | |
+1.76% | 95.28B | |
+1.46% | 22.15B | |
-15.71% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.71% | 16.05B | |
+5.65% | 13.68B | |
+34.44% | 12.17B |